Predictors of Spontaneous and Systematically Assessed Suicidal Adverse Events in the Treatment of SSRI-Resistant Depression in Adolescents (TORDIA) Study
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The authors sought to identify predictors of self-harm adverse events in treatment-resistant, depressed adolescents during the first 12 weeks of treatment. METHOD: Depressed adolescents (N=334) who had not responded to a previous trial with an SSRI antidepressant were randomized to a switch to either another SSRI or venlafaxine, with or without cognitive behavior therapy. Self-harm events, i.e., suicidal and non-suicidal self-injury adverse events were assessed by spontaneous report for the first 181 participants, and by systematic weekly assessment for the last 153 participants. RESULTS: Higher rates of suicidal (20.8% vs. 8.8%) and nonsuicidal self-injury (17.6% vs. 2.2%), but not serious adverse events (8.4% vs. 7.3%) were detected with systematic monitoring. Median time to a suicidal event was 3 weeks, predicted by high baseline suicidal ideation, family conflict, and drug and alcohol use. Median time to nonsuicidal self-injury was 2 weeks, predicted by previous history of nonsuicidal self-injury. While there were no main effects of treatment, venlafaxine treatment was associated with a higher rate of self-harm adverse events in those with higher suicidal ideation. Adjunctive use of benzodiazepines, while in a small number of participants (N=10) was associated with higher rate of both suicidal and nonsuicidal self-injury adverse events. CONCLUSIONS: Since predictors of suicidal adverse events also predict poor response to treatment, and many of these events occurred early in treatment, improving the speed of response to depression, by targeting of family conflict, suicidal ideation, and drug use may help to reduce their incidence. The relationship of venlafaxine and of benzodiazepines to self-harm events requires further study and clinical caution.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“More promisingly, antidepressants reduced suicidal ideation in 9/12 studies that reported effects on suicidal ideation.(55, 57, 59–65)”
From Improving Suicide Prevention Through Evidence-Based Strategies: A Systematic Review (2021) · cites this paper as [65]
In the citing paper
“Three adolescent and young adult RCT studies found antidepressants reduced suicidal ideation,(62, 64, 65) one did not,(85) and none found a reduction in suicide behavior.”
From Improving Suicide Prevention Through Evidence-Based Strategies: A Systematic Review (2021) · cites this paper as [65]
Citations
Cites
Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation
Beck, A. T., Steer, R. A., & Carbin, M. G. (1988) · Clinical Psychology Review · doi:10.1016/0272-7358(88)90050-5 · Cited by 11,696 · cited 2×
“Subjects were assigned to treatment using a variation of Efron’s biased coin toss (15), balancing both across and within sites with respect to incoming treatment medication, comorbid anxiety, chronic depression (duration ≥24 months), and BDI item 9 (suicidal ideation) ≥2.”
MethodKAUFMAN, J., BIRMAHER, B., BRENT, D., RAO, U., FLYNN, C., MORECI, P., WILLIAMSON, D., & RYAN, N. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199707000-00021 · Cited by 10,148 · cited 1×
“Diagnostic information was obtained by the School Age Schedule for Affective Disorders and Schizophrenia for School-Aged Children-Present and Lifetime Version (K-SADS-PL) ( 16 ) at baseline.”
MethodSelf-citationThe measurement of pessimism: the hopelessness scale
Beck, A. T., Weissman, A., Lester, D., & Trexler, L. (1974) · Journal of Consulting and Clinical Psychology · doi:10.1037/h0037562 · Cited by 5,494 · cited 1×
“Self-rated depression, hopelessness, and suicidal ideation were assessed using the Beck Depression Inventory (BDI) (18), Beck Hopelessness Scale (19), and Suicide Ideation Questionnaire—JR (20), respectively.”
MethodA Children's Global Assessment Scale (CGAS)
Shaffer, D. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790100074010 · Cited by 3,716
Non-suicidal self-injury among adolescents: Diagnostic correlates and relation to suicide attempts
NOCK, M., JOINERJR, T., GORDON, K., LLOYDRICHARDSON, E., & PRINSTEIN, M. (2006) · Psychiatry Research · doi:10.1016/j.psychres.2006.05.010 · Cited by 1,617 · cited 1×
“Although the clinical characteristics of those with suicidal and nonsuicidal adverse events overlap ( 27 ), the clinical implications of suicidal adverse events were more serious, insofar as the occurrence of suicidal, but not nonsuicidal self-injury, adverse events was associated with a poorer response to treatment.”
BackgroundA Functional Approach to the Assessment of Self-Mutilative Behavior.
Nock, M. K., & Prinstein, M. J. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.5.885 · Cited by 1,536 · cited 1×
“A “serious suicidal or nonsuicidal self-injury adverse event” was an event that led to hospitalization, was life-threatening, disabling, or resulted in death ( 25 ).”
BackgroundBridge, J. A., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., Ren, L., & Brent, D. A. (2007) · JAMA · doi:10.1001/jama.297.15.1683 · Cited by 1,086 · cited 3×
“During the first half of the study, participants were monitored for self-harm adverse events by spontaneous report, similar to previous studies (1, 10).”
BackgroundResultSelf-citationSuicidality in Pediatric Patients Treated With Antidepressant Drugs
Hammad, T. A., Laughren, T., & Racoosin, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.332 · Cited by 1,054 · cited 3×
“During the first half of the study, participants were monitored for self-harm adverse events by spontaneous report, similar to previous studies (1, 10).”
ResultPosner, K., Oquendo, M. A., Gould, M., Stanley, B., & Davies, M. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.7.1035 · Cited by 1,025 · cited 4×
“This scale consists of two items: 1) a rating of suicidal ideation ranging from 0 to 5 (no ideation to suicidal ideation with intent and a clear plan) and 2) a rating of suicidal behavior, ranging from 0 to 5 (no behavior to multiple attempts during the assessment period) using the Columbia Classification Algorithm of…”
BackgroundMethodInfluential(2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1132 · Cited by 752
Self-citation
Research works printed but not linked: 9
- Apter A, 2006, J Child Adolesc Psychopharmacology, 16
- Hammad T, 2004, US Food and Drug Administration., 19
- Brent DA, JAMA 2008: 901-913
- US Food and Drug Administration, 2003, FDA Talk Paper.
- American Psychiatric Association, 1994, Diagnostic and Statistical Manual of Mental Health-IV
- Poznanski EO, 1984, Depression Rating Scale-Revised. Psychopharmacol Bull, 21, 979
- Guy W, 1976, Clinical Global Improvement Scale: Assessment Manual of Psychopharmacology 76
- Robin AL, 1995, Dictionary of Behavorial Techniques, 148
- Asarnow J, Keller MB
Cited by
Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial
Rossouw, T. I., & Fonagy, P. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.09.018 · Cited by 746
Improving Suicide Prevention Through Evidence-Based Strategies: A Systematic Review
Mann, J. J., Michel, C. A., & Auerbach, R. P. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20060864 · Cited by 655
Wilkinson, P., Kelvin, R., Roberts, C., Dubicka, B., & Goodyer, I. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10050718 · Cited by 645
Asarnow, J. R., Porta, G., Spirito, A., Emslie, G., Clarke, G., Wagner, K. D., Vitiello, B., Keller, M., Birmaher, B., McCracken, J., et al. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2011.04.003 · Cited by 632
Self-citationA Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996–2013
Mrazek, D. A., Hornberger, J. C., Altar, C. A., & Degtiar, I. (2014) · Psychiatric Services · doi:10.1176/appi.ps.201300059 · Cited by 580
Metadata
- Authors
- Brent, D. A., Emslie, G. J., Clarke, G. N., Asarnow, J., Spirito, A., Ritz, L., Vitiello, B., Iyengar, S., Birmaher, B., Ryan, N. D., Zelazny, J., Onorato, M., Kennard, B., Mayes, T. L., DeBar, L. L., McCracken, J. T., Strober, M., Suddath, R., Leonard, H., Porta, G., & Keller, M. B.
- Affiliations
- University of Pittsburgh (US)
- ORCID
- Venue
- American Journal of Psychiatry
- Published
- 2009-04
- Volume
- 166
- Issue
- 4
- Pages
- 418-426
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- PMC
- PMC3593721
- OpenAlex
- W2124714257
- Cited by
- 235
- References
- 34
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 4 · 2023: 17 · 2022: 7 · 2021: 14 · 2020: 19 · 2019: 12 · 2018: 10 · 2017: 10 · 2016: 13 · 2015: 10 · 2014: 14 · 2013: 17 · 2012: 25
- FWCI
- 27.29
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Funders
- Bristol-Myers Squibb
- Pfizer
- National Institute of Mental Health (U01MH061835, U01MH062014)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- non-suicidal self-injury, treatment-resistant depression, adolescent depression, SSRI antidepressants, venlafaxine, cognitive behavioral therapy, suicidal ideation, family conflict, benzodiazepines, adverse event monitoring
- MeSH terms
- Venlafaxine Hydrochloride, Adolescent, Antidepressive Agents, Benzodiazepines, Cross-Sectional Studies, Cyclohexanols, Major Depressive Disorder, Depressive Disorder, Major, Drug Interactions, Drug Resistance, Drug Therapy, Combination, Female, Fluoxetine, Humans, Male, Suicide, Suicide, Attempted, Citalopram, Cognitive Behavioral Therapy, Self-Injurious Behavior, Selective Serotonin Reuptake Inhibitors, Paroxetine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Predictors of Spontaneous and Systematically Assessed Suicidal Adverse Events in the Treatment of SSRI-Resistant Depression in Adolescents (TORDIA) Study. https://app.cochat.ai/papers/10.1176/appi.ajp.2008.08070976
- The paper
- Brent, D. A., Emslie, G. J., Clarke, G. N., Asarnow, J., Spirito, A., Ritz, L., Vitiello, B., Iyengar, S., Birmaher, B., Ryan, N. D., Zelazny, J., Onorato, M., Kennard, B., Mayes, T. L., DeBar, L. L., McCracken, J. T., Strober, M., Suddath, R., Leonard, H., . . . Keller, M. B. (2009). Predictors of Spontaneous and Systematically Assessed Suicidal Adverse Events in the Treatment of SSRI-Resistant Depression in Adolescents (TORDIA) Study. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2008.08070976
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.